These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 31747301)

  • 21. Safety and Treatment Effects of Nusinersen in Longstanding Adult 5q-SMA Type 3 - A Prospective Observational Study.
    Walter MC; Wenninger S; Thiele S; Stauber J; Hiebeler M; Greckl E; Stahl K; Pechmann A; Lochmüller H; Kirschner J; Schoser B
    J Neuromuscul Dis; 2019; 6(4):453-465. PubMed ID: 31594243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distal infantile spinal muscular atrophy associated with paralysis of the diaphragm: a variant of infantile spinal muscular atrophy.
    Bertini E; Gadisseux JL; Palmieri G; Ricci E; Di Capua M; Ferriere G; Lyon G
    Am J Med Genet; 1989 Jul; 33(3):328-35. PubMed ID: 2801766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Respiratory outcomes post nusinersen in spinal muscular atrophy type 1.
    Gonski K; Fitzgerald DA
    Pediatr Pulmonol; 2021 May; 56(5):807-808. PubMed ID: 33316146
    [No Abstract]   [Full Text] [Related]  

  • 24. A comprehensive institutional overview of intrathecal nusinersen injections for spinal muscular atrophy.
    Mousa MA; Aria DJ; Schaefer CM; Kaye RD; Abruzzo TA; Bernes SM; Willard SD; Riemann MC; Towbin RB
    Pediatr Radiol; 2018 Nov; 48(12):1797-1805. PubMed ID: 30022258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nusinersen for the treatment of spinal muscular atrophy.
    Chiriboga CA
    Expert Rev Neurother; 2017 Oct; 17(10):955-962. PubMed ID: 28884620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Congenital segmental spinal muscular atrophy: a case report.
    Savaş T; Erol I; Özkale Y; Saygi S
    J Child Neurol; 2015 Mar; 30(4):509-12. PubMed ID: 25300987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes in type 1 spinal muscular atrophy on nusinersen: A single center experience.
    Kaltman J; Kern-Smith E; Zhang C; Figueroa J; Ritchey M; Razdan R; Verma S
    Clin Neurophysiol; 2020 Dec; 131(12):2793-2794. PubMed ID: 33130439
    [No Abstract]   [Full Text] [Related]  

  • 28. New Frontiers in the Treatment of Spinal Muscular Atrophy.
    Power CL; O'Rourke DJ
    Ir Med J; 2018 Mar; 111(3):705. PubMed ID: 30376223
    [No Abstract]   [Full Text] [Related]  

  • 29. Motor milestone assessment of infants with spinal muscular atrophy using the hammersmith infant neurological Exam-Part 2: Experience from a nusinersen clinical study.
    Bishop KM; Montes J; Finkel RS
    Muscle Nerve; 2018 Jan; 57(1):142-146. PubMed ID: 28556387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paradigm shift in the era of disease-modifying therapies for Spinal Muscular Atrophy type 1: respiratory challenges and opportunities.
    Xiao L; Chiang J; Amin R
    Sleep Med; 2021 Oct; 86():113-115. PubMed ID: 34253462
    [No Abstract]   [Full Text] [Related]  

  • 31. Implementing a Global Expanded Access Program (EAP) for Infantile-Onset Spinal Muscular Atrophy (Type I): Understanding the Imperative, Impact and Challenges.
    Yong J; Moffett M; Lucas S
    J Neuromuscul Dis; 2019; 6(2):227-231. PubMed ID: 31127730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nusinersen in patients older than 7 months with spinal muscular atrophy type 1: A cohort study.
    Aragon-Gawinska K; Seferian AM; Daron A; Gargaun E; Vuillerot C; Cances C; Ropars J; Chouchane M; Cuppen I; Hughes I; Illingworth M; Marini-Bettolo C; Rambaud J; Taytard J; Annoussamy M; Scoto M; Gidaro T; Servais L
    Neurology; 2018 Oct; 91(14):e1312-e1318. PubMed ID: 30158155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of Children with SMA Type 1 Under Treatment with Nusinersen within the Expanded Access Program in Germany.
    Pechmann A; Langer T; Schorling D; Stein S; Vogt S; Schara U; Kölbel H; Schwartz O; Hahn A; Giese K; Johannsen J; Denecke J; Weiß C; Theophil M; Kirschner J
    J Neuromuscul Dis; 2018; 5(2):135-143. PubMed ID: 29689734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current and future treatments of spinal muscular atrophy.
    Smith M
    Dev Med Child Neurol; 2020 Mar; 62(3):267. PubMed ID: 31879942
    [No Abstract]   [Full Text] [Related]  

  • 35. Putting our best foot forward: Clinical, treatment-based and ethical considerations of nusinersen therapy in Canada for spinal muscular atrophy.
    Vukovic S; McAdam L; Zlotnik-Shaul R; Amin R
    J Paediatr Child Health; 2019 Jan; 55(1):18-24. PubMed ID: 30246272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reply to: The 4-Copy Conundrum in the Treatment of Infants with Spinal Muscular Atrophy.
    Yeo CJJ; Simmons Z; De Vivo DC; Darras BT
    Ann Neurol; 2022 Jun; 91(6):892. PubMed ID: 35332578
    [No Abstract]   [Full Text] [Related]  

  • 37. Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy.
    Mercuri E; Darras BT; Chiriboga CA; Day JW; Campbell C; Connolly AM; Iannaccone ST; Kirschner J; Kuntz NL; Saito K; Shieh PB; Tulinius M; Mazzone ES; Montes J; Bishop KM; Yang Q; Foster R; Gheuens S; Bennett CF; Farwell W; Schneider E; De Vivo DC; Finkel RS;
    N Engl J Med; 2018 Feb; 378(7):625-635. PubMed ID: 29443664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nusinersen in spinal muscular atrophy type 1 from neonates to young adult: 1-year data from three Asia-Pacific regions.
    Chan SH; Chae JH; Chien YH; Ko TS; Lee JH; Lee YJ; Nam SO; Jong YJ
    J Neurol Neurosurg Psychiatry; 2021 Nov; 92(11):1244-1246. PubMed ID: 33574081
    [No Abstract]   [Full Text] [Related]  

  • 39. [Respiratory care in spinal muscular atrophy in the new therapeutic era].
    Palomino MA; Castiglioni C
    Rev Chil Pediatr; 2018 Dec; 89(6):685-693. PubMed ID: 30725056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Buying time for infants with spinal muscular atrophy.
    van der Pol L
    Lancet Neurol; 2021 Oct; 20(10):777-779. PubMed ID: 34536396
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.